MAPK3 and colorectal carcinoma: Comparing the growth rates in the 10 cell lines failed to show any correlation between Erk1/2 activity and proliferation speed (Figure 3), initially suggesting to us that relatively low levels of Erk1/2 activation may be sufficient to drive basal cell proliferation in most, if not all, CRC cells.